| Literature DB >> 34243140 |
Lin Lei1, Chang Ke1, Kunyu Xiao1, Linghang Qu1, Xiong Lin1, Xin Zhan1, Jiyuan Tu2, Kang Xu3, Yanju Liu4.
Abstract
Unclear established standard of bran-fried Atractylodis Rhizoma (BFAR), a commonly used drug in Traditional Chinese Medicine (TCM), compromised its clinical efficacy. In this study, we explored the correlation between color and near-infrared spectroscopy (NIR) feature with content of atractylodin, then established a rapid recognition model for the optimal degree of processing for BFAR preparation. The results of the Pearson analysis indicated that the color values were significantly and positively correlated with atractylodin content. The back propagation artificial neural network algorithm and cluster analysis revealed the color of different BFAR could be accurately divided into three categories; subsequently, the color range for the optimal degrees of stir-frying was established as follows: R[red value (105.79-127.25)], G[green value(75.84-89.64)], B[blue value(33.33-42.73)], L[Lightness (81.26-95.09)].Using NIR, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and cluster analysis, three types of BFAR were accurately identified. The prediction model of atractylodin content was established using partial least squares regression analysis. The R2 of the validation set was 0.9717 and the root mean square error was 0.026. In the color judgment model, the processing degree of 8 batches of BFAR from the market is inferior. According to the NIR judgment model, the processing degree of all samples from the market is inferior. In conclusion, the best fire degree of BFAR can be identified quickly and accurately based on our established model. It is a potential method for quality evaluation of Chinese Materia Medica processing.Entities:
Keywords: Bran-fried Atractylodis Rhizoma; Content prediction; Data mining; Intelligent color recognition; Near-infrared spectroscopy; Pattern recognition
Year: 2021 PMID: 34243140 DOI: 10.1016/j.saa.2021.120119
Source DB: PubMed Journal: Spectrochim Acta A Mol Biomol Spectrosc ISSN: 1386-1425 Impact factor: 4.098